Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Top Cited Papers
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 369 (9558) , 275-282
- https://doi.org/10.1016/s0140-6736(07)60149-4
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
This publication has 18 references indexed in Scilit:
- Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness StudyCMAJ : Canadian Medical Association Journal, 2005
- Cost of stroke in EuropeEuropean Journal of Neurology, 2005
- Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical OutcomesArchives of Neurology, 2004
- European Stroke Initiative Recommendations for Stroke Management – Update 2003Cerebrovascular Diseases, 2003
- Guidelines for the Early Management of Patients With Ischemic StrokeStroke, 2003
- Hemorrhagic Transformation of Ischemic Brain TissueStroke, 2001
- Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen ActivatorStroke, 2001
- The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g)Stroke, 2000
- Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter surveyNeurology, 1999
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995